COVID-19: Needle-free vaccine could go through clinical trials

A nurse fills a syringe with a vaccine before administering an injection at a children's clinic in Kiev, Ukraine August 14, 2019. Picture taken August 14, 2019. REUTERS/Valentyn Ogirenko

A vaccine against coronavirus which is needle free could go through clinical trials.

The vaccine was developed by the University of Cambridge can be delivered through a single jet of air.

The name of the vaccine is DIOS-CoVax2.

Sky News reported that the vaccine would be administered through a patient’s skin, eliminating the use of needles and making it pain-free.

To develop this vaccine the University of Cambridge looked at genetic sequences of all known coronaviruses, including those found amongst bats.